


Amivantamab (FUT8-KO)
Ref. TM-T9901A-232
1mg | To inquire | ||
5mg | To inquire |
Product Information
Amivantamab (FUT8-KO) is a humanized dual-specificity antibody targeting EGFR-MET, exhibiting immunotherapeutic anticancer activity. This compound inhibits ligand binding, enhances the internalization and degradation of receptor-antibody complexes, and stimulates macrophage-mediated phagocytosis and natural killer cell cytotoxicity, both of which are Fc-dependent.
Chemical properties
Technical inquiry about: TM-T9901A-232 Amivantamab (FUT8-KO)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.